Ciliatech is delighted to announce the appointment of Coen Van Der Steur to the newly created position of International Business Development Consultant, reporting directly to our Commercial Operations team as part of our growing global organisation.
Coen brings with him an outstanding 34-year track record in the industry, including significant expertise in surgical ophthalmology and, notably, hands-on experience in the field of Minimally Invasive Glaucoma Surgery (MIGS).
Following his early career in the pharmaceutical sector—where he served as both Medical Adviser and International Product Manager—Coen spent 11 years at Bausch & Lomb as Surgical Ophthalmology Business Unit Manager for Central and Eastern Europe, Greece, Turkey, the Middle East, and Africa. During this time, he grew regional sales from $9 million to $25 million. He later joined D.O.R.C., where he held various Director-level roles over a 10-year period, managing sales portfolios across the Middle East, Africa, India, and Asia Pacific, with responsibility for €36 million in annual revenues.
Most recently, Coen served as General Manager for the Middle East Region at Glaukos Corporation. In this role, he built the Glaukos distribution network from the ground up, working closely with US-based Legal, Regulatory Affairs, and Marketing teams to establish a robust infrastructure across the region. His efforts led to insurance coverage for the iStent (a glaucoma implant), the development of partnerships with five key distributors, and the formation of a strong KOL network across both Glaucoma and Keratoconus specialties.
Coen’s appointment marks an exciting chapter for Ciliatech as we continue to expand our international footprint in preparation for the commercial launch of our Intercil® Uveal Spacer. His primary focus will be on the Middle East region, including Bahrain, UAE, Qatar, KSA, Egypt, Iraq, Iran, Jordan, Syria, Lebanon, Israel, Kuwait, Oman, and Turkey.
Coen officially joined Ciliatech on Tuesday 3rd June 2025.
